Shoulder Innovations (SI) Asset Utilization Ratio (2025 - 2026)

Shoulder Innovations' (SI) quarterly Asset Utilization Ratio came in at 0.38 in Q2 2026, up 17.82% quarter-over-quarter from 0.33 in Q1 2026.

Analysis

Shoulder Innovations (SI) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Shoulder Innovations (SI) has reported Asset Utilization Ratio for 2 consecutive years, with 0.38 the latest figure, recorded in Q2 2026.

For the quarter ending Q2 2026, Asset Utilization Ratio changed N/A year-over-year to 0.38; the trailing twelve-month figure through Jun 2026 stood at 0.38 (changed N/A YoY), and the FY2025 full-year result was 0.44, changed N/A from the prior year.
Asset Utilization Ratio grew to 0.38 in Q2 2026 per SI's latest filing, from 0.33 in the prior quarter.
Across five years, Asset Utilization Ratio topped out at 0.38 in Q2 2026 and bottomed at 0.27 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	184.79 Bn	179.19 Bn	7.27 Bn	0.42
2	Intuitive Surgical	124.16 Bn	118.95 Bn	1.96 Bn	0.54
3	Medtronic	118.51 Bn	109.69 Bn	6.34 Bn	0.40
4	Stryker	104.47 Bn	100.99 Bn	4.50 Bn	0.55
5	Boston Scientific	67.20 Bn	66.66 Bn	3.85 Bn	0.47
6	Edwards Lifesciences	49.85 Bn	45.59 Bn	1.35 Bn	0.48
7	Alcon	33.95 Bn	32.49 Bn	1.68 Bn	0.34
8	Dexcom	32.38 Bn	30.44 Bn	830.00 Mn	0.76
9	Steris	21.17 Bn	20.69 Bn	684.20 Mn	0.56
10	Shoulder Innovations	413.68 Mn	314.68 Mn	13.44 Mn	0.38

Historic Data

Download Data